Literature DB >> 32398248

DRESS syndrome: an important differential for eosinophilia with systemic organ dysfunction.

Whoasif Mukit1, Richard Cooper2, Harmesh Moudgil2, Nawaid Ahmad2.   

Abstract

Drug rash occurring with eosinophilia and systemic symptoms syndrome is a potentially fatal adverse drug reaction that requires immediate action in order to minimise patient harm. Initially implicated with the use of anticonvulsants, it has also been shown to be caused by many other medications but less frequently with vancomycin. Patients typically present with fever, lymphadenopathy, eosinophilia and systemic organ dysfunction. Diagnosis is aided using probability calculators such as RegiSCAR (Registry of Severe Cutaneous Adverse Reaction), as well as clinical response on removing the responsible medication. Here, we present a case without any systemic organ dysfunction that improved with withdrawal of the offending drug vancomycin. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute renal failure; drugs and medicines; pharmacology and therapeutics; respiratory system; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2020        PMID: 32398248      PMCID: PMC7222870          DOI: 10.1136/bcr-2020-234251

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Idiosyncratic drug reactions: the reactive metabolite syndromes.

Authors:  S R Knowles; J Uetrecht; N H Shear
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

2.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

3.  Anticonvulsant hypersensitivity syndrome.

Authors:  C C Vittorio; J J Muglia
Journal:  Arch Intern Med       Date:  1995-11-27

Review 4.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

Review 5.  The DRESS syndrome: a literature review.

Authors:  Patrice Cacoub; Philippe Musette; Vincent Descamps; Olivier Meyer; Chris Speirs; Laetitia Finzi; Jean Claude Roujeau
Journal:  Am J Med       Date:  2011-05-17       Impact factor: 4.965

6.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

7.  Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome.

Authors:  G Choquet-Kastylevsky; L Intrator; C Chenal; H Bocquet; J Revuz; J C Roujeau
Journal:  Br J Dermatol       Date:  1998-12       Impact factor: 9.302

Review 8.  DRESS syndrome: Part I. Clinical perspectives.

Authors:  Zain Husain; Bobby Y Reddy; Robert A Schwartz
Journal:  J Am Acad Dermatol       Date:  2013-05       Impact factor: 11.527

9.  Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome.

Authors:  Dong-Hyun Kim; Young-Il Koh
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-06       Impact factor: 5.764

10.  Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature.

Authors:  Abhishek De; Murlidhar Rajagopalan; Aarti Sarda; Sudip Das; Projna Biswas
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.